Skip to main content
. 2024 Jun 3;15:1386607. doi: 10.3389/fimmu.2024.1386607

Figure 13.

Figure 13

Potential therapies that could be beneficial in the treatment of ME/CFS (22, 29, 29, 30, 84, 193, 530, 564580). Created with Biorender.com. IgG, immunoglobulin G; ME/CFS, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; NK, natural killer; NO, nitric oxide; PPAR, peroxisome proliferator-activated receptor; TLR3, toll-like receptor 3; VDR, vitamin D receptor.